$24.24
0.66% yesterday
NYSE, Nov 25, 10:12 pm CET
ISIN
US49177J1025
Symbol
KVUE
Index
Sector
Industry

Kenvue Stock price

$24.24
+1.60 7.07% 1M
+4.89 25.27% 6M
+2.71 12.59% YTD
+4.08 20.24% 1Y
-2.66 9.89% 3Y
-2.66 9.89% 5Y
-2.66 9.89% 10Y
NYSE, Closing price Mon, Nov 25 2024
+0.16 0.66%
ISIN
US49177J1025
Symbol
KVUE
Index
Sector
Industry

Key metrics

Market capitalization $46.47b
Enterprise Value $54.24b
P/E (TTM) P/E ratio 43.74
EV/FCF (TTM) EV/FCF 38.72
EV/Sales (TTM) EV/Sales 3.51
P/S ratio (TTM) P/S ratio 3.01
P/B ratio (TTM) P/B ratio 4.36
Dividend yield 3.34%
Last dividend (FY24) $0.81
Revenue growth (TTM) Revenue growth -0.53%
Revenue (TTM) Revenue $15.46b
EBIT (operating result TTM) EBIT $2.85b
Free Cash Flow (TTM) Free Cash Flow $1.40b
Cash position $1.06b
EPS (TTM) EPS $0.55
P/E forward 40.61
P/S forward 2.98
EV/Sales forward 3.48
Short interest 2.01%
Show more

Is Kenvue a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,883 stocks worldwide.

Kenvue Stock Analysis

Unlock Scores for Free

Analyst Opinions

16 Analysts have issued a Kenvue forecast:

6x Buy
38%
10x Hold
63%

Analyst Opinions

16 Analysts have issued a Kenvue forecast:

Buy
38%
Hold
63%

Financial data from Kenvue

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Sep '24
+/-
%
15,459 15,459
1% 1%
100%
- Direct Costs 6,524 6,524
5% 5%
42%
8,935 8,935
3% 3%
58%
- Selling and Administrative Expenses 5,009 5,009
5% 5%
32%
- Research and Development Expense 435 435
18% 18%
3%
3,491 3,491
1% 1%
23%
- Depreciation and Amortization 646 646
4% 4%
4%
EBIT (Operating Income) EBIT 2,845 2,845
2% 2%
18%
Net Profit 1,064 1,064
32% 32%
7%

In millions USD.

Don't miss a Thing! We will send you all news about Kenvue directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Kenvue Stock News

Neutral
Business Wire
one day ago
SKILLMAN, N.J.--(BUSINESS WIRE)--Kenvue Inc. (NYSE: KVUE) (“Kenvue”) today announced the Company's participation in the Morgan Stanley Global Consumer & Retail Conference in New York City. Thibaut Mongon, Chief Executive Officer and Paul Ruh, Chief Financial Officer will participate in a fireside chat on Wednesday, December 4, 2024, at 11:45 a.m. Eastern Time. A live webcast of the fireside cha...
Positive
Proactive Investors
19 days ago
Kenvue Inc (NYSE:KVUE), the maker of Listerine, Tylenol, Aveeno and Band-Aid, reported slightly lower sales than expected but earnings were just above Wall Street estimates. The company has been in a more intense spotlight coming into these results after reports emerged that activist investor Starboard Value has taken a stake and is eyeing changes.
Neutral
Seeking Alpha
19 days ago
Kenvue, Inc. (NYSE:KVUE ) Q3 2024 Earnings Conference Call November 7, 2024 8:00 AM ET Company Participants Sofya Tsinis - Head, IR Thibaut Mongon - CEO Paul Ruh - CFO Conference Call Participants Bonnie Herzog - Goldman Sachs Anna Lizzul - Bank of America Andrea Teixeira - J.P. Morgan Peter Grom - UBS Filippo Falorni - Citi Steve Powers - Deutsche Bank Keith Devas - Jefferies Nik Modi - RBC Ca...
More Kenvue News

Company Profile

Kenvue, Inc. engages in the provision of healthcare products services. It operates through the following business segments: Self Care, Skin Health and Beauty, and Essential Health. The Self Care segment includes cough, cold and allergy, pain care, digestive health, and smoking cessation. The Skin Health and Beauty segment offers face and body care and hair, sun and others. The Essential Health segment includes oral care, baby care, women’s health and wound care. The company was founded on February 23, 2022 and is headquartered in Skillman, NJ.

Head office United States
CEO Thibaut Mongon
Employees 22,000
Website www.kenvue.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today